<p>Doximity, Inc.（纽约证券交易所代码：DOCS - 获取免费报告）在周四创下 52 周新低，此前一名内部人士出售了该公司的股票。该公司股价最低跌至 17.32 美元，最后交易价格为 17.8060 美元，成交量为 3,490,995 股。该股票此前收盘价为 23.39 美元。</p>
<ul>
<li>Doximity 是医疗社区的 Facebook 和 LinkedIn</li>
</ul>
<p>具体来说，内部人士 Siddharth Sitaram 在 5 月 11 日（星期一）出售了 2,309 股该公司的股票，交易平均价格为 25.77 美元，总交易额为 59,502.93 美元。交易完成后，该内部人士直接持有 89,396 股公司股票，价值为 2,303,734.92 美元。这笔交易代表其持股比例减少了 2.52%。该出售在与证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站获取。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。此外，董事 Kira Scherer Wampler 在 5 月 7 日（星期四）出售了 9,000 股该公司的股票，交易平均价格为 26.06 美元，总交易额为 234,540.00 美元。出售后，该董事持有 19,839 股公司股票，价值约为 517,004.34 美元。这代表其持股比例减少了 31.21%。该出售的 SEC 文件提供了更多信息。该交易是在预先安排的 10b5-1 交易计划下执行的。</p>
<h2>华尔街分析师观点</h2>
<p>多位分析师对该公司发表了评论。Canaccord Genuity Group 在 2 月 9 日（星期一）对 Doximity 设定了 34.00 美元的目标价，并给予该股票 “买入” 评级。摩根士丹利将 Doximity 的目标价从 49.00 美元下调至 35.00 美元，并在周四的报告中对该公司设定了 “增持” 评级。KeyCorp 在周四的研究报告中将 Doximity 的评级从 “增持” 下调至 “行业权重”。BMO 资本市场在周四的研究报告中将 Doximity 的目标价从 25.00 美元下调至 20.00 美元，并对该公司设定了 “市场表现” 评级。最后，Robert W. Baird 在周四的研究报告中重申了 “中性” 评级，并将 Doximity 的目标价设定为 18.00 美元（低于 40.00 美元）。两位股票研究分析师对该股票给予了强烈买入评级，八位给予了买入评级，十三位给予了持有评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “适度买入”，平均目标价为 32.38 美元。</p>
<ul>
<li>Doximity 是一个被忽视的医疗生态系统 AI 投资</li>
</ul>
<p><strong>查看我们最新的 DOCS 股票分析</strong></p>
<h2>更多 Doximity 新闻</h2>
<p>以下是本周影响 Doximity 的主要新闻：</p>
<ul>
<li>积极情绪：Doximity 报告调整后的每股收益为 0.26 美元，超过了一位分析师的预期，收入同比增长 5.1%，达到 1.4537 亿美元，显示出业务仍在增长。Doximity 财报</li>
<li>积极情绪：该公司强调了强劲的盈利能力，包括 37.54% 的净利润率和 23.84% 的股本回报率，支持其高利润率的商业模式。2026 财年第四季度财报快照</li>
<li>中性情绪：内部人士 Siddharth Sitaram 出售了 2,309 股，但该交易是预先安排的 10b5-1 计划的一部分，并与股权归属的税收扣缴相关，因此比自愿出售的担忧要小。内部人士出售披露</li>
<li>消极情绪：投资者关注 Doximity 未能达到更广泛的盈利预期，EPS 为 0.26 美元，而 Zacks 共识为 0.28 美元，这表明本季度的表现不如头条结果所暗示的那样强劲。Doximity 未能达到 2026 财年第四季度盈利预期</li>
<li>消极情绪：更重要的是，管理层对 2027 财年和 2027 财年第一季度的收入指引低于华尔街预期，引发了对增长放缓和与 AI 投资相关的支出增加的担忧。Doximity 2026 财年第四季度电话会议记录</li>
<li>消极情绪：经纪公司也变得更加谨慎，BMO 资本市场将其目标价下调至 20 美元，瑞穗将其目标价下调至 26 美元，进一步强化了对该股票的弱势情绪。分析师目标价变动</li>
</ul>
<h2>Doximity 价格表现</h2>
<ul>
<li>Doximity 股票是一个有趣的医疗投资</li>
</ul>
<p>该公司的市值为 32.8 亿美元，市盈率为 14.84，市盈增长比率为 1.88，贝塔值为 1.36。该股票的 50 日简单移动平均线为 24.27 美元。</p>
<p>Doximity 宣布其董事会已于 2 月 5 日（星期四）批准了一项股票回购计划，授权公司回购 5 亿美元的流通股。该回购授权允许公司通过公开市场购买最多 8% 的股份。股票回购计划通常表明公司领导层认为其股票被低估。</p>
<h2>机构资金流入和流出</h2>
<p>一些大型投资者最近对 DOCS 的持仓进行了调整。加拿大皇家银行在第一季度将其在 Doximity 的持股增加了 24.2%。加拿大皇家银行目前拥有 106,845 股该公司的股票，价值 6,200,000 美元，此前在上个季度又购买了 20,847 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Doximity 的持仓提高了 0.5%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前拥有 38,978 股该公司的股票，价值 2,262,000 美元，此前在上个季度又购买了 210 股。NewEdge Advisors LLC 在第一季度将其在 Doximity 的持股增加了 613.7%。NewEdge Advisors LLC 目前拥有 6,323 股该公司的股票，价值 367,000 美元，此前在上个季度又购买了 5,437 股。高盛集团在第一季度将其在 Doximity 的持股增加了 33.3%。高盛集团目前拥有 255,529 股该公司的股票，价值 14,828,000 美元，此前在上个季度又购买了 63,873 股。最后，Focus Partners Wealth 在第一季度购买了 Doximity 的新持仓，价值 283,000 美元。87.19% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Doximity 公司简介</h2>
<p>(获取免费报告)</p>
<p>Doximity 以 DOCS 的名义运营，是一个数字专业网络和通信平台，主要为临床医生设计。公司总部位于旧金山，连接医生、护士执业者、医师助理和其他医疗专业人员，提供简化临床沟通、远程医疗交付和获取专业特定医疗信息的工具。其平台被定位为一个专业中心，临床医生可以在此管理工作流程、跟进医学新闻并与同行安全协作。</p>
<p>该公司的产品包括安全消息传递和视频远程医疗功能，使临床医生能够在保护患者信息的同时与患者和同事进行咨询。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，而不是 Doximity</li>
<li>eVTOL 投资：抛弃出租车，购买蓝图</li>
<li>伯克希尔的《纽约时报》投资现状如何</li>
<li>Affirm 与谷歌的交易旨在争取你的钱包</li>
<li>保持航班运行的飞机维修公司准备腾飞</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Doximity 吗？</h2>
<p>在考虑 Doximity 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Doximity 并不在名单上。</p>
<p>虽然 Doximity 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

DOCS

LGHT

HEAL

<p>Doximity（纽约证券交易所代码：DOCS）在内部人士出售后，股价达到 52 周新低 17.32 美元，最后交易价格为 17.8060 美元。内部人士 Siddharth Sitaram 以 25.77 美元的价格出售了 2,309 股，而董事 Kira Scherer Wampler 以 26.06 美元的价格出售了 9,000 股。分析师们的看法不一，目标价格范围从 18.00 美元到 34.00 美元不等。尽管报告了 5.1% 的收入增长，但公司未能达到盈利预期，并对 2027 财年的收入指引下调，引发了对增长的担忧。Doximity 的董事会批准了一项 5 亿美元的股票回购计划，显示出对股票价值的信心</p>

<p>Doximity, Inc. (NYSE:DOCS - Get Free Report)'s share price hit a new 52-week low on Thursday after an insider sold shares in the company. The company traded as low as $17.32 and last traded at $17.8060, with a volume of 3490995 shares traded. The stock had previously closed at $23.39.</p>
<div class="lb-trans"><p>Doximity, Inc.（纽约证券交易所代码：DOCS - 获取免费报告）在周四创下 52 周新低，此前一名内部人士出售了该公司的股票。该公司股价最低跌至 17.32 美元，最后交易价格为 17.8060 美元，成交量为 3,490,995 股。该股票此前收盘价为 23.39 美元。</p>
</div><ul>
<li>Doximity is the Facebook and LinkedIn of the Medical Community</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是医疗社区的 Facebook 和 LinkedIn</li>
</ul>
</div><p>Specifically, insider Siddharth Sitaram sold 2,309 shares of the firm's stock in a transaction on Monday, May 11th. The stock was sold at an average price of $25.77, for a total transaction of $59,502.93. Following the completion of the transaction, the insider directly owned 89,396 shares in the company, valued at $2,303,734.92. This trade represents a 2.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the firm's stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $26.06, for a total transaction of $234,540.00. Following the sale, the director owned 19,839 shares of the company's stock, valued at approximately $517,004.34. This represents a 31.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.</p>
<div class="lb-trans"><p>具体来说，内部人士 Siddharth Sitaram 在 5 月 11 日（星期一）出售了 2,309 股该公司的股票，交易平均价格为 25.77 美元，总交易额为 59,502.93 美元。交易完成后，该内部人士直接持有 89,396 股公司股票，价值为 2,303,734.92 美元。这笔交易代表其持股比例减少了 2.52%。该出售在与证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站获取。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。此外，董事 Kira Scherer Wampler 在 5 月 7 日（星期四）出售了 9,000 股该公司的股票，交易平均价格为 26.06 美元，总交易额为 234,540.00 美元。出售后，该董事持有 19,839 股公司股票，价值约为 517,004.34 美元。这代表其持股比例减少了 31.21%。该出售的 SEC 文件提供了更多信息。该交易是在预先安排的 10b5-1 交易计划下执行的。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>A number of analysts have commented on the company. Canaccord Genuity Group set a $34.00 target price on Doximity and gave the stock a &#34;buy&#34; rating in a report on Monday, February 9th. Morgan Stanley reduced their price objective on Doximity from $49.00 to $35.00 and set an &#34;overweight&#34; rating for the company in a report on Thursday. KeyCorp cut shares of Doximity from an &#34;overweight&#34; rating to a &#34;sector weight&#34; rating in a research note on Thursday. BMO Capital Markets reduced their price target on shares of Doximity from $25.00 to $20.00 and set a &#34;market perform&#34; rating for the company in a research note on Thursday. Finally, Robert W. Baird restated a &#34;neutral&#34; rating and set a $18.00 price objective (down from $40.00) on shares of Doximity in a research report on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and thirteen have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of &#34;Moderate Buy&#34; and an average price target of $32.38.</p>
<div class="lb-trans"><p>多位分析师对该公司发表了评论。Canaccord Genuity Group 在 2 月 9 日（星期一）对 Doximity 设定了 34.00 美元的目标价，并给予该股票 “买入” 评级。摩根士丹利将 Doximity 的目标价从 49.00 美元下调至 35.00 美元，并在周四的报告中对该公司设定了 “增持” 评级。KeyCorp 在周四的研究报告中将 Doximity 的评级从 “增持” 下调至 “行业权重”。BMO 资本市场在周四的研究报告中将 Doximity 的目标价从 25.00 美元下调至 20.00 美元，并对该公司设定了 “市场表现” 评级。最后，Robert W. Baird 在周四的研究报告中重申了 “中性” 评级，并将 Doximity 的目标价设定为 18.00 美元（低于 40.00 美元）。两位股票研究分析师对该股票给予了强烈买入评级，八位给予了买入评级，十三位给予了持有评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “适度买入”，平均目标价为 32.38 美元。</p>
</div><ul>
<li>Doximity is an Overlooked Medical Ecosystem AI Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是一个被忽视的医疗生态系统 AI 投资</li>
</ul>
</div><p><strong>View Our Latest Stock Analysis on DOCS</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 DOCS 股票分析</strong></p>
</div><h2>More Doximity News</h2>
<div class="lb-trans"><h2>更多 Doximity 新闻</h2>
</div><p>Here are the key news stories impacting Doximity this week:</p>
<div class="lb-trans"><p>以下是本周影响 Doximity 的主要新闻：</p>
</div><ul>
<li>Positive Sentiment: Doximity reported adjusted EPS of $0.26, topping one analyst estimate, and revenue rose 5.1% year over year to $145.37 million, showing the business is still growing. Doximity Earnings Report</li>
<li>Positive Sentiment: The company highlighted strong profitability, including a 37.54% net margin and 23.84% return on equity, which supports its high-margin business model. Fiscal Q4 Earnings Snapshot</li>
<li>Neutral Sentiment: Insider Siddharth Sitaram sold 2,309 shares, but the transaction was part of a pre-arranged 10b5-1 plan and tied to tax withholding from equity vesting, making it less concerning than a discretionary sale. Insider Sale Disclosure</li>
<li>Negative Sentiment: Investors focused on the fact that Doximity missed broader earnings expectations, with EPS of $0.26 versus the Zacks consensus of $0.28, which suggests the quarter was not as strong as headline results implied. Doximity Lags Q4 Earnings Estimates</li>
<li>Negative Sentiment: More importantly, management’s FY2027 and Q1 FY2027 revenue guidance came in below Wall Street estimates, fueling concerns about slowing growth and higher spending related to AI investments. Doximity Q4 2026 Earnings Call Transcript</li>
<li>Negative Sentiment: Brokerage firms also turned more cautious, with BMO Capital Markets cutting its price target to $20 and Mizuho lowering its target to $26, reinforcing the weaker sentiment around the stock. Analyst Price Target Changes</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：Doximity 报告调整后的每股收益为 0.26 美元，超过了一位分析师的预期，收入同比增长 5.1%，达到 1.4537 亿美元，显示出业务仍在增长。Doximity 财报</li>
<li>积极情绪：该公司强调了强劲的盈利能力，包括 37.54% 的净利润率和 23.84% 的股本回报率，支持其高利润率的商业模式。2026 财年第四季度财报快照</li>
<li>中性情绪：内部人士 Siddharth Sitaram 出售了 2,309 股，但该交易是预先安排的 10b5-1 计划的一部分，并与股权归属的税收扣缴相关，因此比自愿出售的担忧要小。内部人士出售披露</li>
<li>消极情绪：投资者关注 Doximity 未能达到更广泛的盈利预期，EPS 为 0.26 美元，而 Zacks 共识为 0.28 美元，这表明本季度的表现不如头条结果所暗示的那样强劲。Doximity 未能达到 2026 财年第四季度盈利预期</li>
<li>消极情绪：更重要的是，管理层对 2027 财年和 2027 财年第一季度的收入指引低于华尔街预期，引发了对增长放缓和与 AI 投资相关的支出增加的担忧。Doximity 2026 财年第四季度电话会议记录</li>
<li>消极情绪：经纪公司也变得更加谨慎，BMO 资本市场将其目标价下调至 20 美元，瑞穗将其目标价下调至 26 美元，进一步强化了对该股票的弱势情绪。分析师目标价变动</li>
</ul>
</div><h2>Doximity Price Performance</h2>
<div class="lb-trans"><h2>Doximity 价格表现</h2>
</div><ul>
<li>Doximity Stock is an Interesting Healthcare Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 股票是一个有趣的医疗投资</li>
</ul>
</div><p>The company has a market capitalization of $3.28 billion, a P/E ratio of 14.84, a P/E/G ratio of 1.88 and a beta of 1.36. The stock has a fifty day simple moving average of $24.27.</p>
<div class="lb-trans"><p>该公司的市值为 32.8 亿美元，市盈率为 14.84，市盈增长比率为 1.88，贝塔值为 1.36。该股票的 50 日简单移动平均线为 24.27 美元。</p>
</div><p>Doximity declared that its board has approved a stock repurchase program on Thursday, February 5th that authorizes the company to repurchase $500.00 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 8% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's leadership believes its shares are undervalued.</p>
<div class="lb-trans"><p>Doximity 宣布其董事会已于 2 月 5 日（星期四）批准了一项股票回购计划，授权公司回购 5 亿美元的流通股。该回购授权允许公司通过公开市场购买最多 8% 的股份。股票回购计划通常表明公司领导层认为其股票被低估。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of large investors have recently made changes to their positions in DOCS. Royal Bank of Canada lifted its holdings in Doximity by 24.2% in the 1st quarter. Royal Bank of Canada now owns 106,845 shares of the company's stock worth $6,200,000 after purchasing an additional 20,847 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Doximity by 0.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company's stock valued at $2,262,000 after buying an additional 210 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Doximity by 613.7% in the first quarter. NewEdge Advisors LLC now owns 6,323 shares of the company's stock worth $367,000 after buying an additional 5,437 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Doximity by 33.3% in the first quarter. Goldman Sachs Group Inc. now owns 255,529 shares of the company's stock worth $14,828,000 after buying an additional 63,873 shares in the last quarter. Finally, Focus Partners Wealth bought a new position in shares of Doximity during the first quarter worth $283,000. 87.19% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些大型投资者最近对 DOCS 的持仓进行了调整。加拿大皇家银行在第一季度将其在 Doximity 的持股增加了 24.2%。加拿大皇家银行目前拥有 106,845 股该公司的股票，价值 6,200,000 美元，此前在上个季度又购买了 20,847 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Doximity 的持仓提高了 0.5%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前拥有 38,978 股该公司的股票，价值 2,262,000 美元，此前在上个季度又购买了 210 股。NewEdge Advisors LLC 在第一季度将其在 Doximity 的持股增加了 613.7%。NewEdge Advisors LLC 目前拥有 6,323 股该公司的股票，价值 367,000 美元，此前在上个季度又购买了 5,437 股。高盛集团在第一季度将其在 Doximity 的持股增加了 33.3%。高盛集团目前拥有 255,529 股该公司的股票，价值 14,828,000 美元，此前在上个季度又购买了 63,873 股。最后，Focus Partners Wealth 在第一季度购买了 Doximity 的新持仓，价值 283,000 美元。87.19% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Doximity Company Profile</h2>
<div class="lb-trans"><h2>Doximity 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.</p>
<div class="lb-trans"><p>Doximity 以 DOCS 的名义运营，是一个数字专业网络和通信平台，主要为临床医生设计。公司总部位于旧金山，连接医生、护士执业者、医师助理和其他医疗专业人员，提供简化临床沟通、远程医疗交付和获取专业特定医疗信息的工具。其平台被定位为一个专业中心，临床医生可以在此管理工作流程、跟进医学新闻并与同行安全协作。</p>
</div><p>The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.</p>
<div class="lb-trans"><p>该公司的产品包括安全消息传递和视频远程医疗功能，使临床医生能够在保护患者信息的同时与患者和同事进行咨询。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Doximity</li>
<li>eVTOL Investing: Ditch the Taxi, Buy the Blueprint</li>
<li>How Berkshire’s New York Times Bet Looks Today</li>
<li>Affirm's Google Deal Aims for Your Wallet</li>
<li>Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，而不是 Doximity</li>
<li>eVTOL 投资：抛弃出租车，购买蓝图</li>
<li>伯克希尔的《纽约时报》投资现状如何</li>
<li>Affirm 与谷歌的交易旨在争取你的钱包</li>
<li>保持航班运行的飞机维修公司准备腾飞</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Doximity Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Doximity 吗？</h2>
</div><p>Before you consider Doximity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Doximity 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Doximity 并不在名单上。</p>
</div><p>While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Doximity 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Doximity (NYSE:DOCS) Sets New 52-Week Low After Insider Selling

Market Beat

Doximity

Langar Global HealthTech ETF

Global X HealthTech ETF

First Trust Nasdaq Lux Digital Health Solutions ETF

摩根士丹利

科凯国际

蒙特利尔银行

瑞穗金融集团

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

KEYCORP DEP SHS REP 1/40TH NON CUM PER PFD SER G

KEYCORP DEP SHS REPSTG 1/40TH INT PERP NON CUM H

KEYCORP DEP SHS REP 1/40TH PERP PFD SER F USD25

KEYCORP DEP SHS REP 1/40TH NON CUM PFD SER E

Mizuho Financial Group, Inc.

Doximity (NYSE:DOCS) 在内部人士抛售后创下新的 52 周低点